Genetic variations in chemoattractant receptor expressed on Th2 cells (CRTH2) is associated with asthma susceptibility in Chinese children

[1]  J. Celedón,et al.  Genetics of asthma: potential implications for reducing asthma disparities. , 2007, Chest.

[2]  K. Chung,et al.  Complete inhibition of allergic airway inflammation and remodelling in quadruple IL‐4/5/9/13−/− mice , 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[3]  A. Kanda,et al.  Possible Novel Receptor for PGD2 on Human Bronchial Epithelial Cells , 2007, International Archives of Allergy and Immunology.

[4]  M. Nishimura,et al.  Genetic Impact of Functional Single Nucleotide Polymorphisms in the 3′-UTR Region of the Chemoattractant Receptor Expressed on Th2 Cells (CRTH2) Gene on Asthma and Atopy in a Japanese Population , 2006, International Archives of Allergy and Immunology.

[5]  T. Kanaji,et al.  IL-13: a promising therapeutic target for bronchial asthma. , 2006, Current medicinal chemistry.

[6]  E. Kostenis,et al.  Targeting the prostaglandin D2 receptors DP and CRTH2 for treatment of inflammation. , 2006, Current topics in medicinal chemistry.

[7]  Terri H Beaty,et al.  A graphical assessment of p-values from sliding window haplotype tests of association to identify asthma susceptibility loci on chromosome 11q , 2006, BMC Genetics.

[8]  R. Puri,et al.  Role of interleukin-13 in cancer, pulmonary fibrosis, and other T(H)2-type diseases. , 2006, Vitamins and hormones.

[9]  J. M. Mathiesen,et al.  Identification of Indole Derivatives Exclusively Interfering with a G Protein-Independent Signaling Pathway of the Prostaglandin D2 Receptor CRTH2 , 2005, Molecular Pharmacology.

[10]  K. Bacon,et al.  Small-molecule CRTH2 antagonists for the treatment of allergic inflammation: an overview , 2005, Expert opinion on investigational drugs.

[11]  D. Gold,et al.  Elevated Allergen-Induced IL-13 Secretion Predicts IgE Elevation in Children Ages 2–5 Years , 2005, Journal of Clinical Immunology.

[12]  Jing-Long Huang,et al.  Asthma severity and genetics in Taiwan. , 2005, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[13]  S. Fleury,et al.  Activation of the Prostaglandin D2 Receptor DP2/CRTH2 Increases Allergic Inflammation in Mouse 1 , 2005, The Journal of Immunology.

[14]  M. Wills-Karp,et al.  Interleukin‐13 in asthma pathogenesis , 2004, Immunological reviews.

[15]  T. Beaty,et al.  Sequence variants of the gene encoding chemoattractant receptor expressed on Th2 cells (CRTH2) are associated with asthma and differentially influence mRNA stability. , 2004, Human molecular genetics.

[16]  H. Ikeda,et al.  STAT6-mediated signaling in Th2-dependent allergic asthma: critical role for the development of eosinophilia, airway hyper-responsiveness and mucus hypersecretion, distinct from its role in Th2 differentiation. , 2004, International immunology.

[17]  P. O'Byrne,et al.  Reassessing the Th2 cytokine basis of asthma. , 2004, Trends in pharmacological sciences.

[18]  A. Togias,et al.  Genome scan for loci linked to mite sensitivity: the Collaborative Study on the Genetics of Asthma (CSGA) , 2004, Genes and Immunity.

[19]  T. Beaty,et al.  Multipoint linkage disequilibrium mapping for complex diseases , 2003, Genetic epidemiology.

[20]  T. Beaty,et al.  Evidence for asthma susceptibility genes on chromosome 11 in an African-American population , 2003, Human Genetics.

[21]  M. Wills-Karp,et al.  Interleukin-13 in asthma , 2003, Current opinion in pulmonary medicine.

[22]  D. Corry,et al.  Biology and Therapeutic Potential of the Interleukin-4/Interleukin-13 Signaling Pathway in Asthma , 2002, American journal of respiratory medicine : drugs, devices, and other interventions.

[23]  K. Sugamura,et al.  Prostaglandin D2 Selectively Induces Chemotaxis in T Helper Type 2 Cells, Eosinophils, and Basophils via Seven-Transmembrane Receptor Crth2 , 2001, The Journal of experimental medicine.

[24]  R. Homer,et al.  Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. , 1999, The Journal of clinical investigation.